BAX Quote, Financials, Valuation and Earnings

Becton, Dickinson & Co. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 8.37%. Baxter International, Inc.'s return on equity of -4.83% beat Becton, Dickinson & Co.'s return on equity of 6.6%.

Baxter International, Inc. has a consensus price target of $23.67, signalling upside risk potential of 24.69%. On the other hand Becton, Dickinson & Co. has an analysts' consensus of $204.83 which suggests that it could grow by 4.11%. Given that Baxter International, Inc. has higher upside potential than Becton, Dickinson & Co., analysts believe Baxter International, Inc. is more attractive than Becton, Dickinson & Co..

Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison Becton, Dickinson & Co. has a beta of 0.252, suggesting its less volatile than the S&P 500 by 74.828%.

Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.75%. Becton, Dickinson & Co. offers a yield of 2.13% to investors and pays a quarterly dividend of $1.05 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. Becton, Dickinson & Co. pays out 71.53% of its earnings as a dividend. Becton, Dickinson & Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Baxter International, Inc.'s is not.

Baxter International, Inc. quarterly revenues are $2.8B, which are smaller than Becton, Dickinson & Co. quarterly revenues of $5.9B. Baxter International, Inc.'s net income of -$51M is lower than Becton, Dickinson & Co.'s net income of $493M. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while Becton, Dickinson & Co.'s PE ratio is 33.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.88x versus 2.58x for Becton, Dickinson & Co.. Usually stocks with elevated PS ratios are considered overvalued.

Boston Scientific Corp. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 14.91%. Baxter International, Inc.'s return on equity of -4.83% beat Boston Scientific Corp.'s return on equity of 12.46%.

Baxter International, Inc. has a consensus price target of $23.67, signalling upside risk potential of 24.69%. On the other hand Boston Scientific Corp. has an analysts' consensus of $125.86 which suggests that it could grow by 30.52%. Given that Boston Scientific Corp. has higher upside potential than Baxter International, Inc., analysts believe Boston Scientific Corp. is more attractive than Baxter International, Inc..

Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.

Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.75%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.

Baxter International, Inc. quarterly revenues are $2.8B, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Baxter International, Inc.'s net income of -$51M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while Boston Scientific Corp.'s PE ratio is 51.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.88x versus 7.41x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

iRhythm Technologies, Inc. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of -2.7%. Baxter International, Inc.'s return on equity of -4.83% beat iRhythm Technologies, Inc.'s return on equity of -54.18%.

Baxter International, Inc. has a consensus price target of $23.67, signalling upside risk potential of 24.69%. On the other hand iRhythm Technologies, Inc. has an analysts' consensus of $218.60 which suggests that it could grow by 22.5%. Given that Baxter International, Inc. has higher upside potential than iRhythm Technologies, Inc., analysts believe Baxter International, Inc. is more attractive than iRhythm Technologies, Inc..

Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison iRhythm Technologies, Inc. has a beta of 1.099, suggesting its more volatile than the S&P 500 by 9.93%.

Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.75%. iRhythm Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. iRhythm Technologies, Inc. pays out -- of its earnings as a dividend.

Baxter International, Inc. quarterly revenues are $2.8B, which are larger than iRhythm Technologies, Inc. quarterly revenues of $192.9M. Baxter International, Inc.'s net income of -$51M is lower than iRhythm Technologies, Inc.'s net income of -$5.2M. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while iRhythm Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.88x versus 8.07x for iRhythm Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Insulet Corp. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 12.4%. Baxter International, Inc.'s return on equity of -4.83% beat Insulet Corp.'s return on equity of 18.92%.

Baxter International, Inc. has a consensus price target of $23.67, signalling upside risk potential of 24.69%. On the other hand Insulet Corp. has an analysts' consensus of $377.72 which suggests that it could grow by 32.3%. Given that Insulet Corp. has higher upside potential than Baxter International, Inc., analysts believe Insulet Corp. is more attractive than Baxter International, Inc..

Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.374, suggesting its more volatile than the S&P 500 by 37.428%.

Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.75%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

Baxter International, Inc. quarterly revenues are $2.8B, which are larger than Insulet Corp. quarterly revenues of $706.3M. Baxter International, Inc.'s net income of -$51M is lower than Insulet Corp.'s net income of $87.6M. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while Insulet Corp.'s PE ratio is 82.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.88x versus 8.19x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.